Autonomix Medical Announces $5 Million Private Placement Priced at Market Under Nasdaq Rules

Autonomix Medical has priced a $5.0 million private placement, selling 4.5 million shares of common stock and warrants to purchase up to 9.0 million shares. The deal is priced at the market under Nasdaq rules, with gross proceeds before fees and expenses expected to be approximately $5.0 million. Maxim Group LLC is acting as the sole placement agent. The securities are being sold in a private placement under Section 4(a)(2) of the Securities Act.